C. Díaz and C. Zapata, “Profound molecular response with ponatinib in chronic phase of chronic myeloid leukemia with resistance to imatinib and dasatinib: Case report and review of the literature”, Rev Méd Hered, vol. 33, no. 2, pp. 133–138, Jul. 2022.